Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C47H50FNO14 |
| Molecular Weight | 870.8991 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 11 / 11 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3=CC=CC=C3)[C@@H]4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=C([18F])C=C6)C7=CC=CC=C7
InChI
InChIKey=ZWDPMBMJMPIWMJ-LDPXFCOMSA-N
InChI=1S/C47H50FNO14/c1-24-31(61-43(57)36(53)35(27-13-9-7-10-14-27)49-41(55)28-17-19-30(48)20-18-28)22-47(58)40(62-42(56)29-15-11-8-12-16-29)38-45(6,32(52)21-33-46(38,23-59-33)63-26(3)51)39(54)37(60-25(2)50)34(24)44(47,4)5/h7-20,31-33,35-38,40,52-53,58H,21-23H2,1-6H3,(H,49,55)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1/i48-1
| Molecular Formula | C47H50FNO14 |
| Molecular Weight | 870.8991 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 11 / 11 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 22:17:28 GMT 2025
by
admin
on
Tue Apr 01 22:17:28 GMT 2025
|
| Record UNII |
CHP2LM7KK2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5331135
Created by
admin on Tue Apr 01 22:17:28 GMT 2025 , Edited by admin on Tue Apr 01 22:17:28 GMT 2025
|
PRIMARY | |||
|
594848-00-7
Created by
admin on Tue Apr 01 22:17:28 GMT 2025 , Edited by admin on Tue Apr 01 22:17:28 GMT 2025
|
PRIMARY | |||
|
CHP2LM7KK2
Created by
admin on Tue Apr 01 22:17:28 GMT 2025 , Edited by admin on Tue Apr 01 22:17:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
NON-LABELED -> LABELED |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
High 18F-FPAC uptake predicted tumor regression. This relationship was found for mice bearing xenografts from cell lines selected to be either sensitive or intrinsically resistant to paclitaxel in vitro.
|